Target- |
MechanismPancrelipase replacements |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date27 Aug 2009 |
100 Clinical Results associated with Eurand Pharmaceuticals, Inc.
0 Patents (Medical) associated with Eurand Pharmaceuticals, Inc.
100 Deals associated with Eurand Pharmaceuticals, Inc.
100 Translational Medicine associated with Eurand Pharmaceuticals, Inc.